Amcinonide Cream
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Amcinonide Cream is Amcinonide in a suitable cream base. It contains NLT 90.0% and NMT 115.0% of the labeled amount of amcinonide (C28H35FO7).
2 IDENTIFICATION
Change to read:
A. The retention time of the amcinonide peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. (USP 1-Dec-2019)
3 ASSAY
Change to read:
3.1 Procedure
Solution A: Acetonitrile and water (35:65) (USP 1-Dec-2019)
Solution B: Acetonitrile and water (70:30) (USP 1-Dec-2019)
Mobile phase: See Table 1. Equilibrate the system with Solution A.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
|---|---|---|
| 0 | 100 | 0 |
| 2.5 | 100 | 0 |
| 10 | 0 | 100 |
| 25 | 0 | 100 |
| 26 | 100 | 0 |
| 32 | 100 | 0 (USP 1-Dec-2019) |
System suitability solution: 12.5 μg/mL of USP Butylparaben RS (USP 1-Dec-2019) and 20 μg/mL of USP Amcinonide RS in Solution B
Standard solution: 0.02 mg/mL of USP Amcinonide RS in Solution B
Sample stock solution: Nominally 0.2 mg/mL of amcinonide from Cream prepared as follows. Transfer a quantity of Cream, equivalent to 10 mg of amcinonide, to a 50-mL volumetric flask. Add 5 mL of Solution B and 15 mL of acetonitrile, and heat over a steam bath until dissolved. Add 20 mL of Solution B while hot, cool to room temperature, dilute with Solution B to volume, and refrigerate for 30 min.
Vigorously shake the solution to disperse the mixture, and filter while cold. Use the filtrate.
Sample solution: Nominally 0.02 mg/mL of amcinonide from the Sample stock solution (USP 1-Dec-2019) in Solution B
3.2 Chromatographic system
Mode: LC
Detector: UV 254 nm
Column: 4.6-mm × 25-cm; 5-μm (USP 1-Dec-2019) packing L1
Flow rate: 2 mL/min
Injection volume: 10 μL
3.3 System suitability
Samples: System suitability solution and Standard solution
[Note - The relative retention times for butylparaben and amcinonide are 0.78 and 1.0, respectively.]
3.4 Suitability requirements
Resolution: NLT 8.0 between butylparaben and amcinonide, System suitability solution
Tailing factor: NMT 1.5, Standard solution
Relative standard deviation: NMT 2.0%, Standard solution
3.5 Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of amcinonide (C28H35FO7) in the portion of Cream taken:
Result = (ru/rs) × (Cs/Cu) × 100
ru = peak response from the Sample solution
rs = peak response from the Standard solution
Cs = concentration of USP Amcinonide RS in the Standard solution (mg/mL)
Cu = nominal concentration of amcinonide in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–115.0%
4 PERFORMANCE TESTS
Minimum Fill 〈755〉: Meets the requirements
5 SPECIFIC TESTS
Change to read:
Microbial Enumeration Tests 〈61〉 and Tests for Specified Microorganisms 〈62〉: The total aerobic microbial count is NMT 102cfu/g and the totalyeast and mold count is NMT 101cfu/g. (USP 1-Dec-2019) It meets the requirements of the tests for absence of Staphylococcus aureus and Pseudomonas aeruginosa.
pH 〈791〉: 3.5–5.2
6 ADDITIONAL REQUIREMENTS
Change to read:
Packaging and Storage: Preserve in tight containers.▲Store at controlled room temperature.▲ (USP 1-Dec-2019)
Change to read:
USP Reference Standards 〈11〉
USP Amcinonide RS
USP Butylparaben RS

